Sunday 18 October 2026 Export ENTA’s income statement to Excel — free account

Enanta Pharmaceuticals, Inc.

Enanta Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended September 2025) was $65.3 million, down 3.42% from fiscal 2024. In the quarter to June 2026, revenue fell 21.6%, EPS grew 21.2% and free cash flow fell 157.5%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.

11.10 0.37 −3.23%

Follow ENTA

Alert me

Market cap: $334.1M
P/E: 0.0×
Fwd P/E: −5.8×
Dividend yield: —
F-score: 4/9
Altman Z: −1.41
Beneish M: −4.29
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	4	4	4	4
ROE Full definition →		(84.63%)	(60.01%)	(59.00%)	(70.12%)
ROA Full definition →		(24.91%)	(21.10%)	(19.44%)	(21.15%)
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		(42.83%)	(38.00%)	(37.55%)	(34.86%)
Average Days of Receivables Full definition →		38.45	46.28	41.28	36.55
Free Cash Flow per Share Full definition →		(1.51)	(0.64)	(0.33)	(1.27)
Free Cash Flow Full definition →		(32.17)	(18.46)	(9.61)	(36.94)
Capital Expenditures Full definition →		(12.90)	(4.29)	(1.77)	(1.62)
Other line items
Cash ROIC Full definition →		(12.69%)	(5.91%)	(3.43%)	(12.71%)
Accounts Receivable Turnover Full definition →		2.87	2.75	2.86	8.76
Accounts Payable Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Tax Rate Full definition →		(0.02)	(0.02)	0.00	0.00
Research and Development Expense of Revenue Full definition →		163.40%	149.21%	131.94%	132.15%
Selling, General and Administrative Expense of Revenue Full definition →		67.25%	59.86%	55.30%	57.84%
Share Based Compensation of Revenue Full definition →		28.42%	24.95%	22.78%	23.41%
Interest Coverage Full definition →		(11.11)	(8.30)	(5.80)	(4.55)
Operating CF/Net income Full definition →		0.24	0.20	0.13	0.56
Depreciation/Fixed assets Full definition →		0.14	0.14	0.13	0.13
Capex/Depreciation Full definition →		(2.53)	(0.89)	(0.41)	(0.38)
Revenue per Share Full definition →		3.06	2.33	2.38	2.24
Operating CF per Share Full definition →		(0.90)	(0.49)	(0.27)	(1.21)
Capex per Share Full definition →		(0.60)	(0.15)	(0.06)	(0.06)
Capex to Sales Full definition →		0.20	0.06	0.03	0.02

Show all line items

Columns are period end dates

Stockrow Weekly